May 9 (Reuters) - Royalty Pharma PLC ( RPRX ):

* ROYALTY PHARMA TO ACQUIRE ROYALTY INTEREST IN SANOFI'S

FREXALIMAB

* ROYALTY PHARMA ( RPRX ) : PROPOSED DEAL FOR APPROXIMATELY $525

MILLION IN

CASH

* ROYALTY PHARMA ( RPRX ) : EXPANDS CO'S DEVELOPMENT-STAGE PORTFOLIO

TO 15

THERAPIES WITH COMBINED POTENTIAL TO GENERATE GREATER THAN $1

BILLION IN ANNUAL ROYALTIES

Source text for Eikon:

Further company coverage: